Stem Cells Spin S.A. Share Price

Equities

SCS

PLSTCLS00013

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. 03:30:00 25/04/2024 am IST 5-day change 1st Jan Change
0.496 PLN 0.00% Intraday chart for Stem Cells Spin S.A. -0.80% +45.88%

Financials

Sales 2021 526K 130K 10.87M Sales 2022 248K 61.57K 5.13M Capitalization 11.57M 2.87M 239M
Net income 2021 - 0 0 Net income 2022 - 0 0 EV / Sales 2021 56.8 x
Net Debt 2021 338K 83.69K 6.98M Net Debt 2022 400K 99.25K 8.28M EV / Sales 2022 48.2 x
P/E ratio 2021
-232 x
P/E ratio 2022
435 x
Employees 1
Yield 2021 *
-
Yield 2022
-
Free-Float 10.62%
More Fundamentals * Assessed data
Dynamic Chart
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 CI
Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020 CI
Astoria Capital Spólka Akcyjna sold 9.28% stake in Stem Cells Spin Spólka Akcyjna. CI
More news
1 week-0.80%
Current month+5.53%
1 month+3.33%
3 months+24.00%
6 months+48.50%
Current year+45.88%
More quotes
1 week
0.47
Extreme 0.47
0.50
1 month
0.42
Extreme 0.42
0.55
Current year
0.36
Extreme 0.36
0.82
1 year
0.30
Extreme 0.3
0.82
3 years
0.26
Extreme 0.262
1.36
5 years
0.26
Extreme 0.262
2.04
10 years
0.22
Extreme 0.22
2.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 43 01/10/01
Chairman 81 -
Director/Board Member - -
Members of the board TitleAgeSince
Chairman 81 -
Director/Board Member 71 -
Director/Board Member 62 -
More insiders
Date Price Change Volume
25/24/25 0.496 0.00% 678
24/24/24 0.496 -0.80% 50
23/24/23 0.5 0.00% 50
22/24/22 0.5 0.00% 90
19/24/19 0.5 -4.76% 9,488

End-of-day quote Warsaw S.E., April 25, 2024

More quotes
Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.
More about the company